|
Nanocomposite Elastomers : An
Alternate Route to Developing Bioactive Medical Polymers
Laura Poole-Warren, Katie
Styan, Nicole Fong, Brooke Farrugia, Charles Williams,
Anne Simmons
Graduate School of Biomedical Engineering , University of
New South Wales Sydney, NSW, Australia 2052
Thermoplastic polyurethanes
are versatile elastomeric polymers much used for
biomedical applications due to their mechanical properties
and biological performance. Their application as blood
contacting devices ranges from short-term intravenous
catheters through to pumping bladders in left ventricular
assist devices.
The major disadvantages of any
polymer used in these types of applications are that they
are susceptible to bacterial colonisation and to thrombus
formation. Specifically, some polyurethanes are also
susceptible to degradation in vivo. Nanocomposites formed
via blending polymer and nanoparticles have potential
application as antithrombotic and antibacterial materials.
The advantage of nanocomposites over conventional
microcomposites presented in the literature mainly relates
to improved mechanical properties. However, the high
surface area of entrapped nanoparticles and their impact
on the barrier properties of polymers are two features
that can be exploited to produce a material that can
sequester high concentrations of active agent as well as
modulate active agent release. Unlike conventional
techniques for surface modification, this approach has
potential to yield materials that continuously refresh
surface expressed active agents via diffusion of molecules
out of the polymer matrix.
The objective of this research
was to study drug release from polyurethane nanocomposites
and to assess the potential for sustained release of
bioactive molecules.
These studies suggest that
release of low molecular weight compounds from
polyurethane elastomers can be modulated via addition of a
nanoparticle. The bioactivity of the active agent was
retained following processing and release from the system,
confirming the potential of this system for applications
where bioactive agent release could improve device
performance.
Living Free Radical
Polymerization as a Tool for Designing Well-Defined
Materials for Biomedical Applications
Christopher Barner-Kowollik,
Thomas P. Davis, Leonie Barner, Martina H. Stenzel
Centre for Advanced
Macromolecular Design, School of Chemical Sciences and
Chemical Engineering, The University of New South Wales,
NSW 2052, Sydney, Australia
Polymer property design is an
integral part of engineering appropriate materials that
can be employed in biomedical applications ranging from
polymer based drug delivery to polymers for tissue
engineering applications. A particularly powerful tool for
arriving at variable polymer structures is so-called free
radical polymerization. While polymers made via this
method are not biodegradable by themselves, they can be
biocompatible. During the last decade conventional radical
polymerization has been revolutionized with the advent of
techniques that can control the polymer microstructure
with a high degree of precision (i.e. the molecular
weight, polydispersity and architecture). One of the most
prominent of these living radical polymerization (LFRP)
techniques is the so-called reversible addition
fragmentation chain transfer (RAFT) process (1). The paper
highlighted how the RAFT process can be employed to
synthesize polymers of increasing architectural complexity
ranging from block copolymers to multi-block star polymers
with a variable number of arms for a great variety of
monomers, including those of interest for biomedical
applications like vinyl acetate. It also gave selected
examples how LFRP can be employed to assemble amphiphilic
block copolymer structures for self-assembly into nano-containers
for slow release applications, grafting of polymer
surfaces and the synthesis of microspheres of variable
sizes for the use in diagnostic kits and delivery
applications.
Development of Spictra
Membrane Oxygenator System: A Historical Perspective
Muraleedharan CV*, Nagesh DS & Bhuvaneshwar GS
Division of Artificial Organs, Biomedical Technology Wing
, Sree Chitra Tirunal Institute for Medical Sciences &
Technology , Trivandrum – 695012, INDIA
Membrane oxygenators are
devices employed during cardiopulmonary bypass for
facilitating the functions of lungs. SPICTRA Hollow Fiber
Membrane Oxygenator System is a single use gas exchange
device with a self contained venous side heat exchanger
for regulating blood temperature. A hard shell venous
reservoir meant for the storage and filtration of blood is
integrated with the oxygenator module to form the membrane
oxygenator system. The Spictra Hollow Fiber Oxygenator
system is designed to provide low priming volume,
efficient gas exchange and heat transfer efficiency, while
suitable for a wide range of patient sizes. The system has
been evaluated qualified based on the International
Standards ISO 7199: Cardiovascular Implants and Artificial
Organs - Blood Gas Exchangers (Oxygenators).
The various phases of design,
development and technology transfer of this product which
took almost a decade of effort was discussed in the
presentation.
Page 1 |
2 |
3 |
4 |
5 |
6
|